- Home
- MCHX vs IOBT Comparison
MCHX vs IOBT Comparison
Compare MCHX & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- IOBT
- Stock Information
- Founded
- MCHX 2003
- IOBT 2014
- Country
- MCHX United States
- IOBT Denmark
- Employees
- MCHX N/A
- IOBT N/A
- Industry
- MCHX Business Services
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- IOBT Health Care
- Exchange
- MCHX Nasdaq
- IOBT Nasdaq
- Market Cap
- MCHX 84.3M
- IOBT 91.6M
- IPO Year
- MCHX 2004
- IOBT 2021
- Fundamental
- Price
- MCHX $2.01
- IOBT $1.79
- Analyst Decision
- MCHX
- IOBT Strong Buy
- Analyst Count
- MCHX 0
- IOBT 3
- Target Price
- MCHX N/A
- IOBT $9.33
- AVG Volume (30 Days)
- MCHX 40.7K
- IOBT 231.3K
- Earning Date
- MCHX 08-07-2025
- IOBT 08-12-2025
- Dividend Yield
- MCHX N/A
- IOBT N/A
- EPS Growth
- MCHX N/A
- IOBT N/A
- EPS
- MCHX N/A
- IOBT N/A
- Revenue
- MCHX $47,951,000.00
- IOBT N/A
- Revenue This Year
- MCHX $5.77
- IOBT N/A
- Revenue Next Year
- MCHX N/A
- IOBT N/A
- P/E Ratio
- MCHX N/A
- IOBT N/A
- Revenue Growth
- MCHX N/A
- IOBT N/A
- 52 Week Low
- MCHX $1.26
- IOBT $0.66
- 52 Week High
- MCHX $2.40
- IOBT $1.90
- Technical
- Relative Strength Index (RSI)
- MCHX 52.11
- IOBT 68.80
- Support Level
- MCHX $2.02
- IOBT $1.34
- Resistance Level
- MCHX $2.07
- IOBT $1.74
- Average True Range (ATR)
- MCHX 0.10
- IOBT 0.11
- MACD
- MCHX -0.03
- IOBT 0.02
- Stochastic Oscillator
- MCHX 3.70
- IOBT 93.18
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.